U.S. Water Utilities Stock News

NYSE:WTRG
NYSE:WTRGWater Utilities

Assessing Essential Utilities (WTRG) Valuation After Recent Mixed Share Performance

Why Essential Utilities Is On Watch Now Essential Utilities (WTRG) has caught investor attention after a period of mixed share performance, with a small gain over the past month alongside a slight decline over the past 3 months. That backdrop has some investors revisiting the company’s fundamentals, including its regulated water and natural gas businesses and recent financial figures, to decide whether the current pricing fairly reflects its long term prospects. See our latest analysis for...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Assessing Amicus Therapeutics (FOLD) Valuation After A Strong 3 Month Share Price Rally

Amicus Therapeutics (FOLD) has drawn investor attention after a strong past 3 months, with a total return of about 45% and a 1-year total return above 50%, prompting closer scrutiny of its fundamentals. See our latest analysis for Amicus Therapeutics. The recent move in Amicus Therapeutics' share price to $14.36 sits on top of a strong 90 day share price return of about 45%, while the 1 year total shareholder return of roughly 54% points to momentum that has been building rather than...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

MercadoLibre (MELI) Valuation In Focus As Q4 2025 Earnings And JPMorgan Upgrade Draw Attention

MercadoLibre (MELI) is back in focus as investors watch for Q4 2025 earnings after today’s close, with attention on revenue growth, profitability signals, and fresh commentary following a recent JPMorgan upgrade. See our latest analysis for MercadoLibre. The current US$1,864.46 share price comes after a 1 month share price return of 12.77% and a year to date share price return of a 5.53% decline, while the 1 year total shareholder return of a 16.14% decline contrasts with a 3 year total...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Why ImmunityBio (IBRX) Is Up 65.3% After ANKTIVA’s European Approval And New Regional Partnerships

ImmunityBio, Inc. recently reported fourth-quarter 2025 results showing revenue of US$38.29 million versus US$7.55 million a year earlier, alongside a net loss of US$61.94 million, while also securing European conditional marketing authorization and new regional partnerships to commercialize its immunotherapy ANKTIVA across Europe and the Middle East. These moves give ImmunityBio its first broad international commercial footprint for ANKTIVA in bladder cancer and lung cancer, supported by...
NasdaqGM:MDB
NasdaqGM:MDBIT

Assessing MongoDB (MDB) Valuation As AI Commentary And Upcoming Earnings Draw Investor Focus

Interest in MongoDB (MDB) has picked up after fresh analyst commentary framed it as a key database player for GenAI and Agentic AI applications ahead of its upcoming fourth quarter fiscal 2026 earnings report. See our latest analysis for MongoDB. That upbeat GenAI narrative is colliding with a sharp reset in expectations, with the share price at US$305.37 after a 23.6% year to date share price decline, but a 14.3% 1 year total shareholder return that points to longer term confidence holding...
NasdaqGS:AEP
NasdaqGS:AEPElectric Utilities

How Investors Are Reacting To American Electric Power (AEP) Strong 2025 Results And Higher Dividend

American Electric Power Company, Inc. reported past full-year 2025 results showing higher sales of US$21.35 billion and revenue of US$21.88 billion, stronger net income of US$3.58 billion, higher earnings per share, reaffirmed its 2026 operating earnings outlook, and announced that director Henry P. Linginfelter will not stand for re-election in 2026. Alongside these results, AEP increased its quarterly dividend to US$0.95 per share and highlighted a substantial pipeline of infrastructure...
NYSE:DVA
NYSE:DVAHealthcare

Will DaVita’s (DVA) US$5.6 Billion Buybacks and Tech Push Change Its Capital Allocation Narrative

Earlier in February 2026, DaVita Inc. completed two major share repurchase tranches under its 2020 and 2024 buyback programs, retiring millions of shares for a combined outlay of more than US$5.63 billion. This large-scale reduction in share count, alongside CEO Javier Rodriguez’s upcoming appearance at the ViVE 2026 conference in Los Angeles, highlights how DaVita is pairing capital returns with a focus on its long-term care and technology agenda. We’ll now examine how the completion of...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

Will Hub Group’s (HUBG) $77 Million Accounting Restatement Risk Change Its Logistics Growth Narrative

Earlier in 2026, Hub Group disclosed that its quarterly financial reports from March 31, 2025 onward could no longer be relied upon after identifying understated purchased transportation costs and accounts payable, prompting plans to restate results and review internal controls for 2023–2024. The accounting issue, estimated at about US$77,000,000 and now the focus of multiple law firm investigations, has raised fresh questions about the reliability of Hub Group’s recent financial reporting...
NYSE:SCL
NYSE:SCLChemicals

Stepan (SCL) Thin 2% Margin And EPS Slide Reinforce Bearish Narratives In FY 2025

Stepan (SCL) has wrapped up FY 2025 with fourth quarter revenue of US$553.9 million and basic EPS of US$0.22, while trailing twelve month figures show revenue of about US$2.3 billion and EPS of US$2.05. Over recent periods, revenue has moved from US$546.8 million in Q3 2024 to the US$590.3 million to US$594.7 million range across the first three quarters of 2025, with quarterly EPS ranging from US$0.47 to US$0.86, and trailing EPS shifting between US$2.01 and US$2.54. With a trailing net...
NYSE:FET
NYSE:FETEnergy Services

Forum Energy Technologies (FET) Is Up 16.7% After Record Backlog And Buyback Completion - Has The Bull Case Changed?

In February 2026, Forum Energy Technologies reported that Q4 2025 sales were US$202.2 million with net income of US$2.07 million, while completing a US$35.00 million buyback of 1.40 million shares, or 11.68% of its stock, under the repurchase plan announced in December 2024. The company exited 2025 with a US$312.0 million order backlog, the largest in 11 years, and issued 2026 guidance calling for US$800.0–US$880.0 million in revenue, highlighting how improved earnings, a stronger order...
NYSE:MAN
NYSE:MANProfessional Services

Assessing ManpowerGroup (MAN) Valuation After A Prolonged Share Price Slump

Why ManpowerGroup is on investors’ radar ManpowerGroup (MAN) has drawn attention after a prolonged share price slump, with the stock showing negative total returns over the past year, past 3 months, and month. This has prompted investors to reassess its current valuation. See our latest analysis for ManpowerGroup. The share price has reset sharply, with a 1 day share price return of an 8.83% decline and a 30 day share price return of a 14.61% decline, while the 1 year total shareholder return...
NYSE:CUBE
NYSE:CUBESpecialized REITs

CubeSmart JV With CBRE IM Tests Growth Prospects And Valuation Gap

CubeSmart (NYSE:CUBE) has entered a $250 million joint venture with CBRE Investment Management. The partnership is focused on expanding CubeSmart's presence in high growth self storage markets. The new venture comes as the self storage market shows signs of recovery and renewed investor interest. For investors watching NYSE:CUBE at a share price of $39.66, this move adds a fresh layer to the story. The stock is up 12.0% year to date and has returned 34.6% over 5 years, while 1 year and 3...
NYSE:SRE
NYSE:SREIntegrated Utilities

Is It Time To Reassess Sempra (SRE) After Strong Multi Year Share Gains

If you are wondering whether Sempra is fairly priced or if there could be value left on the table, starting with the recent share performance and valuation checks can help frame that question. Sempra shares last closed at US$93.60, with returns of 8.9% over 30 days, 4.3% year to date, 10.9% over 1 year, 33.1% over 3 years, and 86.2% over 5 years. Recent coverage of Sempra has focused on its role as a US utilities player, investor interest in income and infrastructure names, and how these...
NYSE:RH
NYSE:RHSpecialty Retail

Assessing RH (RH) Valuation After Revenue Growth And New Store Concept Rollout

RH (RH) is back in focus after reporting 9% revenue growth in 2025 during what it called the worst housing market in almost 50 years, while rolling out new sourcebooks and reshaping its store footprint. See our latest analysis for RH. RH’s latest sourcebook launches and store footprint changes come against a weak share price backdrop, with a 17.08% 1 month share price decline and a 45.30% 1 year total shareholder return loss. The 90 day share price return of 18.65%, however, hints at...
NasdaqGS:RNW
NasdaqGS:RNWRenewable Energy

A Look At ReNew Energy Global (RNW) Valuation After Robust Q3 Earnings And Upgraded Guidance

ReNew Energy Global (RNW) is back on investors’ radar after its latest earnings release, which highlighted strong year over year revenue growth, higher electricity sales from wind and solar, and a sharp improvement in adjusted EBITDA. See our latest analysis for ReNew Energy Global. Despite the strong Q3 earnings update, ReNew Energy Global’s recent trading has been mixed. The 1-day share price return is 1.67% and the 7-day share price return is 2.62%, compared with a 90-day share price...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Is Harmony Biosciences (HRMY) Pricing Reflect Recent Share Slump And DCF Upside Potential

If you are wondering whether Harmony Biosciences Holdings is attractively priced or misunderstood by the market, you are not alone. This article will walk through what the current share price really implies. The stock last closed at US$26.87, after declines of 25.4% over the past week, 27.0% over the past month, and 21.4% over the past year. These moves may have changed how investors view both its potential and its risks. Recent news coverage around Harmony Biosciences has focused on the...
NYSE:AERO
NYSE:AEROAirlines

Assessing Grupo Aeroméxico (AERO) Valuation After Recent Share Price Volatility

Why Grupo Aeroméxico. de (AERO) is on investors’ radar today Grupo Aeroméxico. de (AERO) has drawn attention after recent trading, with the stock last closing at $18.84. Investors are weighing this price against the company’s current fundamentals and recent return profile. See our latest analysis for Grupo Aeroméxico. de. The recent 1 day share price return of a 10.46% decline has grabbed attention, but it sits alongside a 7 day share price return of 4.67% and a relatively flat 90 day share...
NasdaqGS:MBX
NasdaqGS:MBXPharmaceuticals

Evaluating MBX Biosciences (MBX) Valuation After MBX 2109 Phase 2 Progress And Stronger Investor Sentiment

MBX Biosciences (MBX) is drawing attention after progress updates on its lead therapy MBX 2109 in Phase 2 trials for chronic hypoparathyroidism and early pipeline candidates in other metabolic indications, along with stronger recent investor interest. See our latest analysis for MBX Biosciences. At a recent share price of $36.75, MBX Biosciences has paired a 5.63% 1 day share price return and 16.30% 90 day share price return with a 1 year total shareholder return of about 3.5x. This suggests...
NYSE:OLN
NYSE:OLNChemicals

Assessing Olin (OLN) Valuation As Shares Trade Near US$23.50 With Mixed Recent Returns

Olin (OLN) has caught investor attention after recent trading left the shares around $23.50, with returns mixed across timeframes, including a loss over the past year but a gain over the past three months. See our latest analysis for Olin. That recent drop, including a 3.45% one day share price decline and 9.20% seven day share price decline, sits against a 15.76% 90 day share price return and a 57.88% three year total shareholder return decline. This suggests recent momentum is trying to...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

Did T-Mobile US’ (TMUS) €2.5 Billion Euro Bond Issue Quietly Redefine Its Capital Return Playbook?

T-Mobile US has recently completed a €2.50 billion euro‑denominated senior notes offering, issuing 3.20% notes due 2032 and 3.625% notes due 2035, both senior unsecured and guaranteed, to fund general corporate purposes. This bond deal, backed by a broad syndicate of global banks, increases T-Mobile's financial flexibility to support share repurchases, dividends, and potential debt refinancing. Next, we’ll examine how this €2.50 billion euro bond financing shapes T-Mobile’s investment...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Assessing Microsoft (MSFT) Valuation After Recent Pullback And Fading Share Price Momentum

Microsoft’s recent performance in focus With no single headline event driving Microsoft (MSFT) today, the stock’s recent pullback and current fundamentals are front and center for investors trying to understand how the business and valuation now line up. See our latest analysis for Microsoft. Microsoft’s share price has retreated to US$384.47, with a 1 month share price return of 17.49% and a 3 month share price return of 20.81%, even though the 3 year total shareholder return sits at 57.80%...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

The Bull Case For Dollar Tree (DLTR) Could Change Following Raised EPS Guidance And Tariff Relief Hopes

Dollar Tree recently raised its full-year EPS guidance after reporting a strong quarter, including 4.2% comparable sales growth and 12% adjusted EPS growth to US$1.21, while analysts highlighted both benefits from a Supreme Court tariff ruling and concerns about valuation and limited e-commerce presence. An interesting angle is how the company’s multi-price strategy and potential tariff relief may support margin recovery even as some analysts turn cautious. Next, we’ll examine how Dollar...
NYSE:PL
NYSE:PLProfessional Services

Is Planet Labs (PL) Pricing Reflect Longer Term Growth Expectations After 409% One Year Surge

If you are wondering whether Planet Labs PBC's recent share price puts it at a bargain or a stretch, this is a closer look at what that price might imply about value. The stock closed at US$23.78, with returns of 6.1% over 7 days, an 11.7% decline over 30 days, 16.5% year to date, and 409.2% over the past year, which can change how investors think about both upside and risk. Recent coverage around Planet Labs PBC has focused on its role in satellite data and earth observation services, as...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

Assessing Geron (GERN) Valuation After 2026 RYTELO Revenue Outlook And Pipeline Progress

Geron (GERN) is back in focus after issuing financial guidance for 2026, outlining expected RYTELO net product revenue of US$220 million to US$240 million and highlighting a planned reduction in operating expenses. See our latest analysis for Geron. The new 2026 guidance lands after a sharp run in the share price, with a 90 day share price return of 52.59% and a year to date share price return of 34.09%. However, the 1 year total shareholder return of 25.94% and 3 year total shareholder...